Clinical Trials Logo

Clinical Trial Summary

To investigate the distributions of the patients with ACOS, asthma and COPD over age 40 with chronic airflow limitation in China.


Clinical Trial Description

Sites must be tier 3 hospitals in China. Investigators will mainly be determined according to the following criteria:

- Respiratory physicians working in the respiratory department of tier 3 hospitals

- To include the expected number of patients in a maximum of 12 months, physicians should manage a reasonable number of asthma, COPD or ACOS over age 40 with persistent airflow limitation (post-BD FEV1/FVC<0.7).

- Physicians should have patients' spirometric data available in the patient's medical files (post-BD FEV1%pred and post-BD FEV1/FVC).

This NIS will collect the data (e.g. medical record, patient or physician-reported data) from about 2000 consecutive outpatients with persistent airflow limitation(post-BD FEV1/FVC<0.7) in about 20 sites in China for one year. Each site will recruit about 50-150 patients successively.

The data will be collected under routine clinical practice. The treatments or examinations will be determined by their treating physicians. The data are expected to reflect the actual situation about ACOS.

The study population will be about 2000 outpatients, men or women, over age 40, with a clinical diagnosis of asthma, COPD or ACOS with persistent airflow limitation(post-BD FEV1/FVC<0.7)in China from Q4,2015 to Q3,2016. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02600221
Study type Observational
Source AstraZeneca
Contact
Status Completed
Phase N/A
Start date October 22, 2015
Completion date October 24, 2016

See also
  Status Clinical Trial Phase
Completed NCT03880734 - This Study Include Asthma Chronic Obstructive Pulmonary Disease (COPD) Overlap Patients.Patients Were Vitamin D Deficient.Age Range 40-70 Years, Smokers.Patients Were Advised to Take Either Placebo or Vitamin D3.Lung Functions and Exercise Tolerance Were Assessed at Baseline and at 26th Weeks. Phase 2
Completed NCT03275935 - Evaluation of Inhalation Technique in Patients With COPD, Asthma or ACOS Using a Dry Powder Device (DPI) N/A
Completed NCT04963023 - Biomarkers of Chronic Obstructive Pulmonary Disease
Recruiting NCT03181152 - The Application of Impulse Oscillometry on the Diagnosis of ACOS,Asthma and COPD.
Recruiting NCT03423693 - Small Airway Obstruction in Asthma, COPD, ACOS
Completed NCT03773809 - Impact of Vitamin D3 Administration on Cardiac Autonomic Tone in Asthma Chronic Obstructive Pulmonary Disease(COPD) Overlap Patients N/A
Completed NCT05610514 - Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes Phase 2